Literature DB >> 9478136

Tuberculosis control--is DOTS the health breakthrough of the 1990s?

A Kochi1.   

Abstract

The resurgence of tuberculosis in recent years has made an effective control strategy indispensable. The strategy exists and is called DOTS--Directly Observed Treatment, Short-course. It has proved its effectiveness and now needs to be used worldwide on a much larger scale.

Entities:  

Mesh：

Year:  1997        PMID： 9478136

Source DB:  PubMed          Journal:  World Health Forum        ISSN： 0251-2432


  7 in total

1.  Tuberculosis and the poverty-disease cycle.

Authors:  J Grange; A Zumla
Journal:  J R Soc Med       Date:  1999-03       Impact factor: 5.344

Review 2.  Pharmacokinetic factors in the modern drug treatment of tuberculosis.

Authors:  J G Douglas; M J McLeod
Journal:  Clin Pharmacokinet       Date:  1999-08       Impact factor: 6.447

Review 3.  Research on implementation of interventions in tuberculosis control in low- and middle-income countries: a systematic review.

Authors:  Frank Cobelens; Sanne van Kampen; Eleanor Ochodo; Rifat Atun; Christian Lienhardt
Journal:  PLoS Med       Date:  2012-12-18       Impact factor: 11.069

4.  Extensively Drug-Resistant Tuberculosis: A Sign of the Times and an Impetus for Antimicrobial Discovery.

Authors:  Shelley E Haydel
Journal:  Pharmaceuticals (Basel)       Date:  2010-07-01

5.  Psychiatric morbidity and other factors affecting treatment adherence in pulmonary tuberculosis patients.

Authors:  Argiro Pachi; Dionisios Bratis; Georgios Moussas; Athanasios Tselebis
Journal:  Tuberc Res Treat       Date:  2013-04-15

6.  The structural modeling of the interaction between levofloxacin and the Mycobacterium tuberculosis gyrase catalytic site sheds light on the mechanisms of fluoroquinolones resistant tuberculosis in Colombian clinical isolates.

Authors:  N Alvarez; E Zapata; G I Mejía; T Realpe; P Araque; C Peláez; F Rouzaud; J Robledo
Journal:  Biomed Res Int       Date:  2014-04-28       Impact factor: 3.411

7.  Double Standards in Global Health: Medicine, Human Rights Law and Multidrug-Resistant TB Treatment Policy.

Authors:  Thomas Nicholson; Catherine Admay; Aaron Shakow; Salmaan Keshavjee
Journal:  Health Hum Rights       Date:  2016-06
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.